| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Statistical | 47 | 2023 | 5079 | 2.520 |
Why?
|
| Prostatectomy | 46 | 2023 | 1824 | 2.510 |
Why?
|
| Biometry | 32 | 2019 | 563 | 2.440 |
Why?
|
| Prostatic Neoplasms | 77 | 2024 | 11122 | 2.210 |
Why?
|
| Surgical Procedures, Operative | 40 | 2024 | 1924 | 1.850 |
Why?
|
| Cystectomy | 16 | 2020 | 634 | 1.630 |
Why?
|
| Urinary Bladder Neoplasms | 23 | 2024 | 2223 | 1.450 |
Why?
|
| Checklist | 19 | 2024 | 827 | 1.390 |
Why?
|
| Prostate-Specific Antigen | 17 | 2024 | 2469 | 1.330 |
Why?
|
| Regression Analysis | 30 | 2019 | 6345 | 1.330 |
Why?
|
| Data Interpretation, Statistical | 30 | 2022 | 2691 | 1.300 |
Why?
|
| Likelihood Functions | 24 | 2023 | 992 | 1.300 |
Why?
|
| Bayes Theorem | 9 | 2022 | 2330 | 1.300 |
Why?
|
| Healthcare Disparities | 27 | 2024 | 3358 | 1.260 |
Why?
|
| General Surgery | 23 | 2021 | 1692 | 1.090 |
Why?
|
| Electronic Health Records | 27 | 2024 | 4811 | 1.070 |
Why?
|
| Hospitals | 34 | 2024 | 3883 | 1.050 |
Why?
|
| Medical Errors | 18 | 2024 | 1263 | 0.990 |
Why?
|
| Quality Improvement | 30 | 2024 | 3802 | 0.970 |
Why?
|
| Accidental Falls | 10 | 2023 | 1068 | 0.970 |
Why?
|
| Humans | 605 | 2024 | 761596 | 0.960 |
Why?
|
| Male | 387 | 2024 | 360846 | 0.930 |
Why?
|
| Quality Indicators, Health Care | 20 | 2024 | 1792 | 0.920 |
Why?
|
| Aged | 255 | 2024 | 169310 | 0.870 |
Why?
|
| United States | 167 | 2024 | 72340 | 0.840 |
Why?
|
| SEER Program | 27 | 2024 | 1450 | 0.830 |
Why?
|
| Postoperative Complications | 52 | 2024 | 15633 | 0.820 |
Why?
|
| Patient Discharge | 15 | 2024 | 3443 | 0.810 |
Why?
|
| Robotics | 16 | 2012 | 819 | 0.810 |
Why?
|
| Female | 362 | 2024 | 392705 | 0.770 |
Why?
|
| Hospital Mortality | 24 | 2023 | 5293 | 0.750 |
Why?
|
| Medicare | 41 | 2024 | 6770 | 0.740 |
Why?
|
| Operating Rooms | 15 | 2020 | 789 | 0.730 |
Why?
|
| Clinical Competence | 23 | 2021 | 4793 | 0.730 |
Why?
|
| Middle Aged | 243 | 2024 | 220921 | 0.730 |
Why?
|
| Decision Support Systems, Clinical | 10 | 2024 | 1175 | 0.720 |
Why?
|
| Nephrectomy | 9 | 2020 | 937 | 0.710 |
Why?
|
| Algorithms | 21 | 2024 | 14033 | 0.710 |
Why?
|
| Logistic Models | 46 | 2023 | 13255 | 0.700 |
Why?
|
| Survival Analysis | 29 | 2022 | 10090 | 0.690 |
Why?
|
| Computer Simulation | 30 | 2023 | 6241 | 0.670 |
Why?
|
| Linear Models | 27 | 2024 | 5872 | 0.670 |
Why?
|
| Terminal Care | 12 | 2023 | 1761 | 0.670 |
Why?
|
| Patient Readmission | 18 | 2022 | 3271 | 0.670 |
Why?
|
| Laparoscopy | 18 | 2023 | 2036 | 0.660 |
Why?
|
| Prostate | 9 | 2023 | 1773 | 0.660 |
Why?
|
| Arthroplasty, Replacement, Knee | 11 | 2023 | 1393 | 0.650 |
Why?
|
| Binomial Distribution | 2 | 2014 | 23 | 0.630 |
Why?
|
| Medication Errors | 8 | 2023 | 783 | 0.630 |
Why?
|
| Multivariate Analysis | 31 | 2024 | 12059 | 0.620 |
Why?
|
| Patient Care Team | 14 | 2024 | 2521 | 0.590 |
Why?
|
| Health Services Accessibility | 20 | 2023 | 5440 | 0.580 |
Why?
|
| Cluster Analysis | 14 | 2022 | 2707 | 0.570 |
Why?
|
| Retrospective Studies | 116 | 2024 | 80647 | 0.570 |
Why?
|
| Primary Health Care | 13 | 2024 | 4687 | 0.570 |
Why?
|
| Early Detection of Cancer | 14 | 2023 | 3201 | 0.570 |
Why?
|
| Hospitalization | 23 | 2024 | 10721 | 0.560 |
Why?
|
| Antibiotics, Antineoplastic | 11 | 2012 | 678 | 0.560 |
Why?
|
| Normal Distribution | 4 | 2022 | 272 | 0.560 |
Why?
|
| Inpatients | 15 | 2024 | 2548 | 0.560 |
Why?
|
| Adult | 188 | 2024 | 221210 | 0.560 |
Why?
|
| Patient-Centered Care | 10 | 2021 | 1421 | 0.550 |
Why?
|
| Venous Thromboembolism | 4 | 2024 | 1866 | 0.550 |
Why?
|
| Mammaplasty | 12 | 2016 | 1239 | 0.540 |
Why?
|
| Urology | 3 | 2017 | 400 | 0.540 |
Why?
|
| Neoplasms | 33 | 2023 | 22173 | 0.530 |
Why?
|
| Proportional Hazards Models | 21 | 2021 | 12463 | 0.510 |
Why?
|
| Health Care Costs | 13 | 2023 | 3242 | 0.490 |
Why?
|
| Wounds and Injuries | 11 | 2020 | 2492 | 0.490 |
Why?
|
| Doxorubicin | 15 | 2013 | 2224 | 0.480 |
Why?
|
| Health Care Surveys | 12 | 2019 | 2426 | 0.470 |
Why?
|
| Space Flight | 3 | 2022 | 215 | 0.470 |
Why?
|
| Comparative Effectiveness Research | 4 | 2018 | 709 | 0.470 |
Why?
|
| Aged, 80 and over | 83 | 2024 | 58984 | 0.470 |
Why?
|
| Quality of Health Care | 19 | 2024 | 4331 | 0.470 |
Why?
|
| Kidney Neoplasms | 9 | 2024 | 4251 | 0.470 |
Why?
|
| Attitude of Health Personnel | 15 | 2024 | 3889 | 0.470 |
Why?
|
| Delivery, Obstetric | 7 | 2024 | 941 | 0.460 |
Why?
|
| Kallikreins | 2 | 2017 | 220 | 0.460 |
Why?
|
| Emergency Treatment | 6 | 2020 | 496 | 0.450 |
Why?
|
| Length of Stay | 29 | 2024 | 6426 | 0.450 |
Why?
|
| Hypertension | 14 | 2024 | 8540 | 0.450 |
Why?
|
| Tourniquets | 3 | 2019 | 107 | 0.450 |
Why?
|
| Risk | 11 | 2017 | 9610 | 0.440 |
Why?
|
| Breast Neoplasms | 33 | 2024 | 21019 | 0.440 |
Why?
|
| Medically Uninsured | 8 | 2018 | 836 | 0.440 |
Why?
|
| Risk Assessment | 45 | 2024 | 23996 | 0.440 |
Why?
|
| Physicians | 13 | 2024 | 4591 | 0.430 |
Why?
|
| Longitudinal Studies | 31 | 2023 | 14608 | 0.420 |
Why?
|
| Guideline Adherence | 13 | 2020 | 2220 | 0.420 |
Why?
|
| Propensity Score | 13 | 2023 | 1913 | 0.420 |
Why?
|
| Internship and Residency | 15 | 2021 | 5882 | 0.410 |
Why?
|
| Hospital Costs | 7 | 2017 | 947 | 0.410 |
Why?
|
| Monte Carlo Method | 8 | 2019 | 1258 | 0.410 |
Why?
|
| Arthroplasty, Replacement, Hip | 6 | 2022 | 1413 | 0.400 |
Why?
|
| Treatment Outcome | 81 | 2024 | 64685 | 0.400 |
Why?
|
| Prostatic Hyperplasia | 3 | 2024 | 521 | 0.400 |
Why?
|
| Infusion Pumps | 4 | 2023 | 163 | 0.400 |
Why?
|
| Liver Transplantation | 2 | 2023 | 2330 | 0.390 |
Why?
|
| Research Design | 13 | 2023 | 6180 | 0.390 |
Why?
|
| Carcinoma, Transitional Cell | 4 | 2021 | 783 | 0.390 |
Why?
|
| Survival Rate | 30 | 2021 | 12723 | 0.390 |
Why?
|
| Lymph Node Excision | 8 | 2019 | 1271 | 0.390 |
Why?
|
| Pain, Postoperative | 6 | 2021 | 1740 | 0.380 |
Why?
|
| Communication | 14 | 2023 | 3875 | 0.380 |
Why?
|
| Educational Measurement | 6 | 2021 | 1255 | 0.380 |
Why?
|
| Learning Curve | 4 | 2020 | 230 | 0.380 |
Why?
|
| Drug Prescriptions | 5 | 2024 | 1670 | 0.380 |
Why?
|
| Electronic Mail | 4 | 2023 | 213 | 0.370 |
Why?
|
| Military Medicine | 3 | 2017 | 184 | 0.370 |
Why?
|
| Patient Satisfaction | 10 | 2019 | 3462 | 0.370 |
Why?
|
| Diffusion of Innovation | 5 | 2018 | 728 | 0.370 |
Why?
|
| Maternal Health Services | 4 | 2022 | 462 | 0.370 |
Why?
|
| Kidney Transplantation | 3 | 2023 | 4235 | 0.360 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 14 | 2013 | 1551 | 0.360 |
Why?
|
| World Health Organization | 12 | 2020 | 1322 | 0.350 |
Why?
|
| Palliative Care | 7 | 2024 | 3598 | 0.350 |
Why?
|
| Neoplasm Staging | 27 | 2021 | 11120 | 0.350 |
Why?
|
| Medicaid | 8 | 2023 | 2818 | 0.350 |
Why?
|
| Specialties, Surgical | 4 | 2023 | 389 | 0.350 |
Why?
|
| Health Knowledge, Attitudes, Practice | 10 | 2024 | 4016 | 0.340 |
Why?
|
| Patient Participation | 7 | 2024 | 1445 | 0.340 |
Why?
|
| Chi-Square Distribution | 15 | 2023 | 3415 | 0.340 |
Why?
|
| Cross-Sectional Studies | 40 | 2024 | 26129 | 0.340 |
Why?
|
| Intensive Care Units | 7 | 2023 | 3744 | 0.340 |
Why?
|
| Ambulatory Surgical Procedures | 4 | 2024 | 464 | 0.340 |
Why?
|
| Infusions, Intravenous | 10 | 2023 | 2217 | 0.330 |
Why?
|
| Neoadjuvant Therapy | 8 | 2019 | 2828 | 0.330 |
Why?
|
| Patient Acceptance of Health Care | 9 | 2020 | 3206 | 0.330 |
Why?
|
| Physicians, Primary Care | 4 | 2024 | 623 | 0.330 |
Why?
|
| Time Factors | 51 | 2024 | 39969 | 0.330 |
Why?
|
| Clinical Trials as Topic | 11 | 2018 | 8002 | 0.330 |
Why?
|
| Razoxane | 4 | 2012 | 43 | 0.320 |
Why?
|
| Survivors | 13 | 2023 | 2371 | 0.320 |
Why?
|
| Health Expenditures | 9 | 2023 | 2366 | 0.320 |
Why?
|
| Urinary Bladder | 7 | 2023 | 1152 | 0.310 |
Why?
|
| Fee-for-Service Plans | 4 | 2017 | 700 | 0.310 |
Why?
|
| Medical Oncology | 3 | 2019 | 2321 | 0.310 |
Why?
|
| Colorectal Neoplasms | 13 | 2023 | 6938 | 0.310 |
Why?
|
| Emergencies | 6 | 2022 | 1217 | 0.310 |
Why?
|
| Analgesics, Opioid | 8 | 2024 | 3808 | 0.310 |
Why?
|
| Electronics | 7 | 2022 | 318 | 0.310 |
Why?
|
| Accidents, Occupational | 1 | 2010 | 249 | 0.300 |
Why?
|
| Mastectomy | 10 | 2020 | 1822 | 0.300 |
Why?
|
| Video Recording | 5 | 2021 | 967 | 0.300 |
Why?
|
| Trauma Centers | 6 | 2021 | 937 | 0.300 |
Why?
|
| Antihypertensive Agents | 5 | 2024 | 2024 | 0.290 |
Why?
|
| Muscle Neoplasms | 2 | 2019 | 130 | 0.290 |
Why?
|
| Dementia | 4 | 2024 | 2689 | 0.290 |
Why?
|
| Risk Factors | 65 | 2024 | 74213 | 0.290 |
Why?
|
| Mastectomy, Segmental | 5 | 2017 | 955 | 0.290 |
Why?
|
| Prospective Studies | 52 | 2024 | 54423 | 0.290 |
Why?
|
| Advance Care Planning | 4 | 2019 | 699 | 0.290 |
Why?
|
| Analysis of Variance | 14 | 2016 | 6228 | 0.290 |
Why?
|
| Intraoperative Complications | 6 | 2013 | 1166 | 0.290 |
Why?
|
| Safety Management | 7 | 2013 | 760 | 0.280 |
Why?
|
| Delivery of Health Care | 6 | 2023 | 5337 | 0.280 |
Why?
|
| Education, Medical, Graduate | 7 | 2021 | 2373 | 0.280 |
Why?
|
| Patient Protection and Affordable Care Act | 7 | 2023 | 1188 | 0.280 |
Why?
|
| Vascular Surgical Procedures | 7 | 2020 | 1489 | 0.270 |
Why?
|
| Androgen Antagonists | 4 | 2019 | 1410 | 0.270 |
Why?
|
| Statistics as Topic | 6 | 2014 | 2358 | 0.270 |
Why?
|
| Quality Assurance, Health Care | 8 | 2017 | 2169 | 0.270 |
Why?
|
| Databases, Factual | 23 | 2020 | 7968 | 0.270 |
Why?
|
| Diabetes Complications | 5 | 2014 | 1315 | 0.270 |
Why?
|
| Confidence Intervals | 10 | 2014 | 2927 | 0.270 |
Why?
|
| Hospitals, Community | 4 | 2024 | 365 | 0.260 |
Why?
|
| Maternal Mortality | 6 | 2020 | 302 | 0.260 |
Why?
|
| Watchful Waiting | 3 | 2023 | 491 | 0.260 |
Why?
|
| Nurses | 5 | 2020 | 2478 | 0.260 |
Why?
|
| Cocaine-Related Disorders | 2 | 2020 | 461 | 0.260 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2024 | 2242 | 0.260 |
Why?
|
| Colectomy | 7 | 2022 | 688 | 0.260 |
Why?
|
| Laser Therapy | 2 | 2023 | 1092 | 0.260 |
Why?
|
| Oximetry | 3 | 2015 | 459 | 0.250 |
Why?
|
| Clinical Trials, Phase III as Topic | 3 | 2010 | 857 | 0.250 |
Why?
|
| Muscles | 3 | 2019 | 1576 | 0.250 |
Why?
|
| Workload | 5 | 2016 | 844 | 0.250 |
Why?
|
| Perinatal Mortality | 3 | 2020 | 101 | 0.250 |
Why?
|
| Chemotherapy, Adjuvant | 9 | 2019 | 3514 | 0.250 |
Why?
|
| Poisson Distribution | 4 | 2015 | 504 | 0.240 |
Why?
|
| Cohort Studies | 33 | 2023 | 41495 | 0.240 |
Why?
|
| Hemorrhage | 5 | 2022 | 3424 | 0.240 |
Why?
|
| Developing Countries | 6 | 2021 | 2885 | 0.240 |
Why?
|
| Critical Care | 7 | 2023 | 2697 | 0.240 |
Why?
|
| Quality of Life | 12 | 2023 | 13367 | 0.240 |
Why?
|
| Appendectomy | 3 | 2019 | 433 | 0.240 |
Why?
|
| Odds Ratio | 19 | 2017 | 9647 | 0.240 |
Why?
|
| Transurethral Resection of Prostate | 3 | 2022 | 79 | 0.230 |
Why?
|
| Appendicitis | 3 | 2019 | 675 | 0.230 |
Why?
|
| Follow-Up Studies | 37 | 2021 | 39106 | 0.230 |
Why?
|
| Postoperative Period | 5 | 2021 | 1814 | 0.230 |
Why?
|
| Cesarean Section | 6 | 2022 | 1398 | 0.230 |
Why?
|
| Surgery, Computer-Assisted | 5 | 2012 | 1007 | 0.230 |
Why?
|
| Socioeconomic Factors | 21 | 2020 | 7828 | 0.230 |
Why?
|
| Patient Simulation | 2 | 2018 | 298 | 0.230 |
Why?
|
| Occupations | 2 | 2017 | 515 | 0.230 |
Why?
|
| Hospitals, Pediatric | 5 | 2024 | 1860 | 0.230 |
Why?
|
| Anthracyclines | 3 | 2012 | 284 | 0.230 |
Why?
|
| Ischemia | 6 | 2013 | 1884 | 0.230 |
Why?
|
| Statistics, Nonparametric | 7 | 2019 | 2850 | 0.230 |
Why?
|
| Rectal Neoplasms | 4 | 2020 | 1157 | 0.230 |
Why?
|
| Hospice Care | 3 | 2023 | 678 | 0.220 |
Why?
|
| Erectile Dysfunction | 6 | 2017 | 444 | 0.220 |
Why?
|
| South Carolina | 8 | 2017 | 101 | 0.220 |
Why?
|
| Heart Diseases | 10 | 2013 | 2781 | 0.220 |
Why?
|
| Health Education | 2 | 2021 | 1052 | 0.220 |
Why?
|
| Neoplasm Invasiveness | 10 | 2019 | 3597 | 0.220 |
Why?
|
| Randomized Controlled Trials as Topic | 16 | 2022 | 10212 | 0.220 |
Why?
|
| Reproducibility of Results | 19 | 2024 | 20100 | 0.220 |
Why?
|
| Physician-Patient Relations | 6 | 2019 | 3251 | 0.220 |
Why?
|
| Benchmarking | 8 | 2018 | 1045 | 0.220 |
Why?
|
| Ethics Consultation | 1 | 2024 | 59 | 0.220 |
Why?
|
| Cardiotoxins | 2 | 2013 | 36 | 0.220 |
Why?
|
| Surgery Department, Hospital | 4 | 2012 | 176 | 0.220 |
Why?
|
| Minority Groups | 7 | 2024 | 1203 | 0.210 |
Why?
|
| Child | 65 | 2024 | 80158 | 0.210 |
Why?
|
| Ventricular Septum | 1 | 2023 | 76 | 0.210 |
Why?
|
| Artificial Limbs | 1 | 2024 | 121 | 0.210 |
Why?
|
| Patient Admission | 3 | 2024 | 1367 | 0.210 |
Why?
|
| Extremities | 3 | 2018 | 867 | 0.210 |
Why?
|
| Attitude to Computers | 4 | 2018 | 196 | 0.210 |
Why?
|
| Efficiency | 3 | 2016 | 476 | 0.210 |
Why?
|
| Decision Support Techniques | 3 | 2018 | 1998 | 0.210 |
Why?
|
| Erythroblasts | 1 | 2023 | 142 | 0.210 |
Why?
|
| Adolescent | 60 | 2024 | 88326 | 0.210 |
Why?
|
| Medical Records Systems, Computerized | 4 | 2009 | 1192 | 0.210 |
Why?
|
| Iodine | 3 | 2022 | 288 | 0.210 |
Why?
|
| Data Mining | 3 | 2013 | 551 | 0.210 |
Why?
|
| Reimbursement Mechanisms | 2 | 2019 | 667 | 0.210 |
Why?
|
| Boston | 20 | 2021 | 9327 | 0.210 |
Why?
|
| Respiratory Insufficiency | 2 | 2022 | 1230 | 0.210 |
Why?
|
| Astronauts | 2 | 2022 | 92 | 0.210 |
Why?
|
| Medical Audit | 4 | 2016 | 453 | 0.210 |
Why?
|
| Population Surveillance | 3 | 2010 | 2598 | 0.200 |
Why?
|
| Pharmaceutical Preparations | 5 | 2023 | 1089 | 0.200 |
Why?
|
| Military Personnel | 6 | 2019 | 1246 | 0.200 |
Why?
|
| First Aid | 2 | 2019 | 69 | 0.200 |
Why?
|
| Urethral Obstruction | 1 | 2022 | 55 | 0.200 |
Why?
|
| Pulmonary Atresia | 1 | 2023 | 159 | 0.200 |
Why?
|
| Surgery, Plastic | 3 | 2016 | 643 | 0.200 |
Why?
|
| Esophagectomy | 2 | 2020 | 468 | 0.200 |
Why?
|
| Medication Systems, Hospital | 3 | 2018 | 154 | 0.200 |
Why?
|
| Registries | 10 | 2023 | 8225 | 0.200 |
Why?
|
| Documentation | 4 | 2024 | 897 | 0.200 |
Why?
|
| Cryotherapy | 2 | 2014 | 159 | 0.200 |
Why?
|
| Hip Fractures | 2 | 2024 | 988 | 0.200 |
Why?
|
| Least-Squares Analysis | 4 | 1998 | 369 | 0.200 |
Why?
|
| Independent Living | 2 | 2024 | 579 | 0.200 |
Why?
|
| Ambulatory Care | 5 | 2024 | 2775 | 0.200 |
Why?
|
| Urination | 3 | 2012 | 203 | 0.200 |
Why?
|
| Probability | 12 | 2023 | 2477 | 0.200 |
Why?
|
| Infant, Low Birth Weight | 2 | 2023 | 870 | 0.200 |
Why?
|
| Perception | 3 | 2018 | 1197 | 0.200 |
Why?
|
| Telephone | 3 | 2014 | 627 | 0.200 |
Why?
|
| Young Adult | 36 | 2024 | 59260 | 0.190 |
Why?
|
| Age Factors | 20 | 2018 | 18399 | 0.190 |
Why?
|
| Hospital Information Systems | 2 | 2017 | 394 | 0.190 |
Why?
|
| Medical Order Entry Systems | 3 | 2013 | 521 | 0.190 |
Why?
|
| Massachusetts | 15 | 2024 | 8833 | 0.190 |
Why?
|
| Aftercare | 4 | 2023 | 914 | 0.190 |
Why?
|
| Radiotherapy, Adjuvant | 8 | 2017 | 1784 | 0.190 |
Why?
|
| Aerospace Medicine | 1 | 2022 | 95 | 0.190 |
Why?
|
| Program Evaluation | 7 | 2018 | 2495 | 0.190 |
Why?
|
| Echocardiography | 15 | 2013 | 4989 | 0.190 |
Why?
|
| Colorectal Surgery | 1 | 2023 | 122 | 0.190 |
Why?
|
| Behavior Therapy | 3 | 2014 | 879 | 0.180 |
Why?
|
| Comorbidity | 14 | 2018 | 10508 | 0.180 |
Why?
|
| Biostatistics | 3 | 2015 | 164 | 0.180 |
Why?
|
| Peer Group | 2 | 2020 | 692 | 0.180 |
Why?
|
| Health Records, Personal | 2 | 2012 | 127 | 0.180 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 14 | 2019 | 11742 | 0.180 |
Why?
|
| Access to Information | 1 | 2023 | 316 | 0.180 |
Why?
|
| Age Distribution | 10 | 2013 | 2879 | 0.180 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2020 | 942 | 0.180 |
Why?
|
| Sex Distribution | 9 | 2016 | 2280 | 0.180 |
Why?
|
| Preoperative Care | 5 | 2016 | 2242 | 0.180 |
Why?
|
| Hospital Administration | 2 | 2014 | 353 | 0.180 |
Why?
|
| Carcinoma, Ductal, Breast | 4 | 2012 | 1085 | 0.170 |
Why?
|
| Sex Factors | 15 | 2024 | 10554 | 0.170 |
Why?
|
| Preventive Health Services | 2 | 2018 | 567 | 0.170 |
Why?
|
| Nurse Midwives | 1 | 2020 | 23 | 0.170 |
Why?
|
| Opiate Substitution Treatment | 1 | 2024 | 444 | 0.170 |
Why?
|
| Psychotherapy | 2 | 2020 | 1647 | 0.170 |
Why?
|
| Ureteral Neoplasms | 1 | 2021 | 107 | 0.170 |
Why?
|
| Combined Modality Therapy | 15 | 2019 | 8527 | 0.170 |
Why?
|
| Mars | 1 | 2019 | 28 | 0.170 |
Why?
|
| Convalescence | 1 | 2020 | 105 | 0.170 |
Why?
|
| Pandemics | 10 | 2024 | 8656 | 0.170 |
Why?
|
| Urinary Incontinence | 6 | 2017 | 489 | 0.170 |
Why?
|
| Pulmonary Valve | 1 | 2023 | 411 | 0.170 |
Why?
|
| Delayed Diagnosis | 1 | 2024 | 463 | 0.170 |
Why?
|
| Software | 8 | 2023 | 4434 | 0.170 |
Why?
|
| Injury Severity Score | 7 | 2020 | 1045 | 0.170 |
Why?
|
| Leadership | 6 | 2021 | 1385 | 0.170 |
Why?
|
| Heart | 8 | 2024 | 4404 | 0.170 |
Why?
|
| Diabetes Mellitus | 5 | 2022 | 5841 | 0.170 |
Why?
|
| Telemedicine | 3 | 2024 | 3052 | 0.170 |
Why?
|
| Diverticulitis | 1 | 2022 | 185 | 0.170 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 282 | 0.170 |
Why?
|
| Troponin T | 7 | 2012 | 780 | 0.160 |
Why?
|
| Acinetobacter Infections | 1 | 2019 | 73 | 0.160 |
Why?
|
| Thinness | 1 | 2023 | 490 | 0.160 |
Why?
|
| Tracheostomy | 1 | 2023 | 426 | 0.160 |
Why?
|
| Respiratory Sounds | 8 | 2006 | 702 | 0.160 |
Why?
|
| Sample Size | 4 | 2014 | 841 | 0.160 |
Why?
|
| Brachytherapy | 3 | 2018 | 1223 | 0.160 |
Why?
|
| Veterans | 5 | 2022 | 2649 | 0.160 |
Why?
|
| Residence Characteristics | 4 | 2022 | 2095 | 0.160 |
Why?
|
| Cancer Care Facilities | 4 | 2018 | 422 | 0.160 |
Why?
|
| Thoracic Outlet Syndrome | 1 | 2020 | 97 | 0.160 |
Why?
|
| Labor, Obstetric | 2 | 2024 | 323 | 0.160 |
Why?
|
| Family Practice | 1 | 2002 | 512 | 0.160 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2010 | 2571 | 0.160 |
Why?
|
| Blood Pressure | 8 | 2021 | 8481 | 0.160 |
Why?
|
| Patient Education as Topic | 4 | 2021 | 2319 | 0.160 |
Why?
|
| Prosthesis Design | 2 | 2024 | 2115 | 0.160 |
Why?
|
| India | 7 | 2020 | 2348 | 0.160 |
Why?
|
| Insurance Coverage | 7 | 2023 | 1940 | 0.160 |
Why?
|
| Tibia | 1 | 2024 | 1070 | 0.160 |
Why?
|
| Urban Health | 2 | 2006 | 532 | 0.160 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2023 | 1553 | 0.160 |
Why?
|
| Adenocarcinoma | 8 | 2017 | 6345 | 0.160 |
Why?
|
| Opioid-Related Disorders | 3 | 2024 | 2164 | 0.160 |
Why?
|
| Cardiovascular Diseases | 11 | 2018 | 15502 | 0.160 |
Why?
|
| Child, Preschool | 36 | 2023 | 42232 | 0.150 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 3 | 2017 | 926 | 0.150 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2022 | 1228 | 0.150 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2002 | 662 | 0.150 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2020 | 115 | 0.150 |
Why?
|
| Surgical Sponges | 2 | 2008 | 39 | 0.150 |
Why?
|
| Minority Health | 1 | 2019 | 79 | 0.150 |
Why?
|
| Surgical Flaps | 4 | 2010 | 1671 | 0.150 |
Why?
|
| Health Facilities | 2 | 2020 | 580 | 0.150 |
Why?
|
| Academic Medical Centers | 10 | 2023 | 2759 | 0.150 |
Why?
|
| Body Mass Index | 13 | 2022 | 12953 | 0.150 |
Why?
|
| Tetralogy of Fallot | 1 | 2023 | 618 | 0.150 |
Why?
|
| Mouth Neoplasms | 1 | 2023 | 596 | 0.150 |
Why?
|
| Kidney Failure, Chronic | 5 | 2017 | 2472 | 0.150 |
Why?
|
| Inservice Training | 3 | 2017 | 376 | 0.150 |
Why?
|
| Incidence | 20 | 2023 | 21355 | 0.150 |
Why?
|
| Esophageal Neoplasms | 3 | 2020 | 1654 | 0.150 |
Why?
|
| Child, Hospitalized | 2 | 2017 | 182 | 0.150 |
Why?
|
| Infant, Newborn | 20 | 2023 | 26202 | 0.150 |
Why?
|
| Adiposity | 4 | 2013 | 1879 | 0.150 |
Why?
|
| Liver Neoplasms | 8 | 2023 | 4317 | 0.150 |
Why?
|
| Communications Media | 1 | 2018 | 42 | 0.150 |
Why?
|
| Cardiomyopathies | 5 | 2012 | 1964 | 0.150 |
Why?
|
| Patients | 2 | 2016 | 907 | 0.150 |
Why?
|
| Decision Trees | 1 | 2019 | 504 | 0.150 |
Why?
|
| Microcomputers | 1 | 2018 | 141 | 0.150 |
Why?
|
| Health Surveys | 7 | 2018 | 4061 | 0.150 |
Why?
|
| Surgical Instruments | 2 | 2012 | 383 | 0.150 |
Why?
|
| Life Expectancy | 5 | 2019 | 1243 | 0.150 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2019 | 3165 | 0.140 |
Why?
|
| Equipment Safety | 2 | 2016 | 249 | 0.140 |
Why?
|
| Wound Infection | 1 | 2019 | 246 | 0.140 |
Why?
|
| Professional-Family Relations | 2 | 2018 | 495 | 0.140 |
Why?
|
| Hospitals, Teaching | 4 | 2017 | 1156 | 0.140 |
Why?
|
| Nutrition Surveys | 5 | 2024 | 1733 | 0.140 |
Why?
|
| Psychometrics | 4 | 2020 | 3065 | 0.140 |
Why?
|
| Fontan Procedure | 1 | 2023 | 796 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 10 | 2018 | 6484 | 0.140 |
Why?
|
| Appendiceal Neoplasms | 1 | 2019 | 155 | 0.140 |
Why?
|
| Periodontal Diseases | 2 | 2019 | 451 | 0.140 |
Why?
|
| Competency-Based Education | 2 | 2010 | 222 | 0.140 |
Why?
|
| Travel | 1 | 2023 | 796 | 0.140 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2024 | 1050 | 0.140 |
Why?
|
| Physical Exertion | 1 | 2020 | 667 | 0.140 |
Why?
|
| Health Care Reform | 4 | 2019 | 1247 | 0.140 |
Why?
|
| Lung Neoplasms | 6 | 2024 | 13381 | 0.140 |
Why?
|
| Malpractice | 8 | 2007 | 556 | 0.140 |
Why?
|
| Feedback | 2 | 2023 | 791 | 0.140 |
Why?
|
| Physicians, Family | 2 | 2009 | 350 | 0.140 |
Why?
|
| Clinical Clerkship | 3 | 2013 | 564 | 0.140 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2023 | 846 | 0.140 |
Why?
|
| Diagnostic Tests, Routine | 3 | 2018 | 787 | 0.130 |
Why?
|
| Health Status Disparities | 3 | 2023 | 1853 | 0.130 |
Why?
|
| Hospital Units | 1 | 2017 | 142 | 0.130 |
Why?
|
| Buprenorphine | 1 | 2024 | 656 | 0.130 |
Why?
|
| Salvage Therapy | 2 | 2014 | 1263 | 0.130 |
Why?
|
| Sentinel Lymph Node Biopsy | 3 | 2010 | 732 | 0.130 |
Why?
|
| Forecasting | 3 | 2017 | 2928 | 0.130 |
Why?
|
| Urologic Neoplasms | 2 | 2017 | 314 | 0.130 |
Why?
|
| Meta-Analysis as Topic | 1 | 2001 | 1380 | 0.130 |
Why?
|
| Intestinal Obstruction | 2 | 2018 | 432 | 0.130 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2009 | 488 | 0.130 |
Why?
|
| Medical Staff, Hospital | 2 | 2011 | 601 | 0.130 |
Why?
|
| Surgicenters | 1 | 2016 | 50 | 0.130 |
Why?
|
| Midwifery | 1 | 2017 | 125 | 0.130 |
Why?
|
| Health Communication | 1 | 2019 | 213 | 0.130 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2017 | 109 | 0.130 |
Why?
|
| Hypoalbuminemia | 1 | 2016 | 86 | 0.130 |
Why?
|
| Patient Compliance | 4 | 2014 | 2690 | 0.130 |
Why?
|
| National Health Insurance, United States | 1 | 2016 | 100 | 0.130 |
Why?
|
| Health Status Indicators | 3 | 2011 | 970 | 0.130 |
Why?
|
| Markov Chains | 2 | 2019 | 966 | 0.130 |
Why?
|
| Lawyers | 1 | 2016 | 38 | 0.130 |
Why?
|
| Health Resources | 3 | 2013 | 935 | 0.130 |
Why?
|
| Surgical Wound Infection | 5 | 2016 | 1529 | 0.130 |
Why?
|
| Substance-Related Disorders | 3 | 2023 | 4420 | 0.130 |
Why?
|
| Nurse-Patient Relations | 1 | 2016 | 100 | 0.130 |
Why?
|
| Postoperative Care | 3 | 2021 | 1468 | 0.130 |
Why?
|
| Behavioral Risk Factor Surveillance System | 4 | 2019 | 209 | 0.130 |
Why?
|
| Coronary Disease | 3 | 2005 | 5914 | 0.130 |
Why?
|
| Lymphatic Metastasis | 6 | 2019 | 2915 | 0.130 |
Why?
|
| Wounds, Gunshot | 1 | 2021 | 582 | 0.130 |
Why?
|
| Diagnosis | 2 | 2024 | 157 | 0.130 |
Why?
|
| Critical Illness | 6 | 2020 | 2723 | 0.130 |
Why?
|
| Task Performance and Analysis | 3 | 2018 | 763 | 0.130 |
Why?
|
| Medication Adherence | 4 | 2021 | 2176 | 0.130 |
Why?
|
| Health Behavior | 5 | 2022 | 2644 | 0.130 |
Why?
|
| Predictive Value of Tests | 15 | 2023 | 15266 | 0.130 |
Why?
|
| Recovery of Function | 7 | 2020 | 2979 | 0.130 |
Why?
|
| Pilot Projects | 11 | 2020 | 8633 | 0.130 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2018 | 2020 | 0.130 |
Why?
|
| Ventricular Function, Left | 9 | 2012 | 3879 | 0.120 |
Why?
|
| Personnel, Hospital | 1 | 2017 | 285 | 0.120 |
Why?
|
| Epidemiologic Methods | 4 | 2012 | 1336 | 0.120 |
Why?
|
| Sampling Studies | 4 | 2015 | 615 | 0.120 |
Why?
|
| Cross-Cultural Comparison | 1 | 1998 | 635 | 0.120 |
Why?
|
| Veterans Health | 1 | 2017 | 215 | 0.120 |
Why?
|
| Pseudomonas Infections | 1 | 2019 | 622 | 0.120 |
Why?
|
| National Health Programs | 1 | 1998 | 440 | 0.120 |
Why?
|
| Clinical Protocols | 2 | 2018 | 1440 | 0.120 |
Why?
|
| Carcinoma in Situ | 2 | 2012 | 791 | 0.120 |
Why?
|
| Urothelium | 1 | 2017 | 269 | 0.120 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2016 | 195 | 0.120 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2023 | 2244 | 0.120 |
Why?
|
| Mutagenicity Tests | 1 | 1994 | 46 | 0.120 |
Why?
|
| Population Density | 1 | 2015 | 193 | 0.120 |
Why?
|
| HIV | 1 | 2002 | 1582 | 0.120 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2017 | 257 | 0.120 |
Why?
|
| Oxytocics | 1 | 2015 | 67 | 0.120 |
Why?
|
| Controlled Clinical Trials as Topic | 2 | 2009 | 186 | 0.120 |
Why?
|
| Reminder Systems | 1 | 2018 | 388 | 0.120 |
Why?
|
| Endpoint Determination | 1 | 2017 | 590 | 0.120 |
Why?
|
| Marital Status | 1 | 2016 | 426 | 0.120 |
Why?
|
| Heart Arrest | 3 | 2021 | 1514 | 0.120 |
Why?
|
| Ghana | 3 | 2020 | 315 | 0.120 |
Why?
|
| Emergency Service, Hospital | 6 | 2021 | 7879 | 0.120 |
Why?
|
| Goals | 2 | 2019 | 711 | 0.120 |
Why?
|
| Health Services Needs and Demand | 3 | 2019 | 1403 | 0.120 |
Why?
|
| Pregnancy | 16 | 2024 | 29890 | 0.120 |
Why?
|
| Office Visits | 2 | 2016 | 595 | 0.120 |
Why?
|
| Tachycardia, Ventricular | 1 | 2023 | 1304 | 0.120 |
Why?
|
| Postpartum Period | 2 | 2018 | 1175 | 0.120 |
Why?
|
| Medical Records | 4 | 2012 | 1408 | 0.120 |
Why?
|
| Unnecessary Procedures | 3 | 2017 | 415 | 0.120 |
Why?
|
| Cardiovascular Agents | 4 | 2010 | 840 | 0.120 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2017 | 333 | 0.120 |
Why?
|
| Endovascular Procedures | 2 | 2022 | 2183 | 0.120 |
Why?
|
| Nursing Services | 1 | 2013 | 6 | 0.120 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2007 | 416 | 0.120 |
Why?
|
| Traumatology | 1 | 2015 | 100 | 0.110 |
Why?
|
| Health Status | 5 | 2018 | 4077 | 0.110 |
Why?
|
| Pneumonia | 4 | 2020 | 2143 | 0.110 |
Why?
|
| Terminally Ill | 1 | 2016 | 240 | 0.110 |
Why?
|
| Guidelines as Topic | 3 | 2017 | 1386 | 0.110 |
Why?
|
| Managed Care Programs | 1 | 2019 | 940 | 0.110 |
Why?
|
| Infant Mortality | 2 | 2016 | 759 | 0.110 |
Why?
|
| Insurance Benefits | 1 | 2016 | 187 | 0.110 |
Why?
|
| Coronary Artery Bypass | 3 | 2019 | 2188 | 0.110 |
Why?
|
| Biomedical Technology | 1 | 2016 | 211 | 0.110 |
Why?
|
| Disease-Free Survival | 10 | 2013 | 6815 | 0.110 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2016 | 572 | 0.110 |
Why?
|
| Toxicology | 1 | 1994 | 102 | 0.110 |
Why?
|
| Case-Control Studies | 9 | 2024 | 22176 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 7 | 2024 | 7391 | 0.110 |
Why?
|
| Foreign Bodies | 2 | 2008 | 402 | 0.110 |
Why?
|
| Child Health Services | 3 | 2013 | 646 | 0.110 |
Why?
|
| Smoking | 9 | 2024 | 9053 | 0.110 |
Why?
|
| Computers | 1 | 2016 | 593 | 0.110 |
Why?
|
| Education, Medical | 2 | 2017 | 1725 | 0.110 |
Why?
|
| Vaginal Smears | 2 | 2021 | 499 | 0.110 |
Why?
|
| Colonic Neoplasms | 2 | 2024 | 2539 | 0.110 |
Why?
|
| Health Promotion | 3 | 2018 | 2214 | 0.110 |
Why?
|
| Computational Biology | 2 | 2005 | 3517 | 0.110 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2015 | 232 | 0.110 |
Why?
|
| Cost Savings | 4 | 2023 | 913 | 0.110 |
Why?
|
| Infant | 25 | 2023 | 36193 | 0.110 |
Why?
|
| Siblings | 3 | 2013 | 825 | 0.110 |
Why?
|
| Problem-Based Learning | 1 | 2017 | 356 | 0.110 |
Why?
|
| Ethics, Medical | 1 | 1998 | 783 | 0.110 |
Why?
|
| Directive Counseling | 1 | 2014 | 170 | 0.110 |
Why?
|
| Respiration, Artificial | 2 | 2023 | 2630 | 0.110 |
Why?
|
| Nursing Care | 1 | 2013 | 65 | 0.110 |
Why?
|
| Certificate of Need | 1 | 2012 | 12 | 0.110 |
Why?
|
| Air Pollution | 6 | 1996 | 2359 | 0.110 |
Why?
|
| Intention | 1 | 2016 | 347 | 0.110 |
Why?
|
| Muscle, Smooth | 1 | 2017 | 926 | 0.110 |
Why?
|
| Leg | 2 | 2009 | 1088 | 0.110 |
Why?
|
| Heart Ventricles | 5 | 2024 | 3807 | 0.110 |
Why?
|
| Mammography | 6 | 2021 | 2430 | 0.110 |
Why?
|
| Florida | 3 | 2018 | 431 | 0.110 |
Why?
|
| Capacity Building | 1 | 2015 | 258 | 0.100 |
Why?
|
| Antineoplastic Agents | 11 | 2016 | 13642 | 0.100 |
Why?
|
| Spinal Fusion | 2 | 2019 | 1286 | 0.100 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 982 | 0.100 |
Why?
|
| Surgical Stomas | 1 | 2012 | 42 | 0.100 |
Why?
|
| Referral and Consultation | 3 | 2023 | 3600 | 0.100 |
Why?
|
| Vocabulary, Controlled | 1 | 2013 | 167 | 0.100 |
Why?
|
| Muscle Tonus | 1 | 2012 | 82 | 0.100 |
Why?
|
| Blood Transfusion | 6 | 2017 | 1301 | 0.100 |
Why?
|
| Neoplasm Metastasis | 6 | 2023 | 4915 | 0.100 |
Why?
|
| Hospitals, Military | 3 | 2017 | 62 | 0.100 |
Why?
|
| Matched-Pair Analysis | 2 | 2003 | 284 | 0.100 |
Why?
|
| Triage | 1 | 2019 | 986 | 0.100 |
Why?
|
| Burnout, Professional | 1 | 2021 | 704 | 0.100 |
Why?
|
| Hospital Administrators | 1 | 2012 | 57 | 0.100 |
Why?
|
| Internationality | 3 | 2016 | 1001 | 0.100 |
Why?
|
| Personnel Selection | 1 | 2014 | 196 | 0.100 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2024 | 1462 | 0.100 |
Why?
|
| Testicular Neoplasms | 1 | 2018 | 799 | 0.100 |
Why?
|
| Manikins | 1 | 2014 | 244 | 0.100 |
Why?
|
| Hormone Replacement Therapy | 1 | 2018 | 751 | 0.100 |
Why?
|
| Ventricular Remodeling | 3 | 2023 | 1267 | 0.100 |
Why?
|
| Insurance Carriers | 1 | 2014 | 156 | 0.100 |
Why?
|
| Health Services | 1 | 2017 | 752 | 0.100 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2018 | 1148 | 0.100 |
Why?
|
| Smoking Cessation | 1 | 2024 | 2057 | 0.100 |
Why?
|
| Pneumonectomy | 2 | 2017 | 1119 | 0.100 |
Why?
|
| Hemochromatosis | 1 | 2013 | 174 | 0.100 |
Why?
|
| Professional Competence | 1 | 2015 | 431 | 0.100 |
Why?
|
| Caregivers | 2 | 2023 | 2238 | 0.100 |
Why?
|
| Endarterectomy, Carotid | 1 | 2017 | 555 | 0.100 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1924 | 0.100 |
Why?
|
| Depression | 3 | 2023 | 8126 | 0.100 |
Why?
|
| Internet | 2 | 2016 | 3093 | 0.100 |
Why?
|
| Heart Defects, Congenital | 3 | 2023 | 4671 | 0.100 |
Why?
|
| Postpartum Hemorrhage | 1 | 2015 | 272 | 0.090 |
Why?
|
| Thromboembolism | 1 | 2018 | 995 | 0.090 |
Why?
|
| Data Collection | 6 | 2011 | 3322 | 0.090 |
Why?
|
| Interprofessional Relations | 3 | 2015 | 990 | 0.090 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2019 | 1520 | 0.090 |
Why?
|
| Thyroid Neoplasms | 3 | 2022 | 2332 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2024 | 36426 | 0.090 |
Why?
|
| Veins | 3 | 2010 | 768 | 0.090 |
Why?
|
| Anal Canal | 1 | 2014 | 373 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 8 | 2017 | 9280 | 0.090 |
Why?
|
| Geographic Information Systems | 2 | 2020 | 281 | 0.090 |
Why?
|
| Oxytocin | 1 | 2015 | 402 | 0.090 |
Why?
|
| Patient Selection | 3 | 2020 | 4244 | 0.090 |
Why?
|
| Health Care Coalitions | 1 | 2011 | 36 | 0.090 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 8601 | 0.090 |
Why?
|
| Economic Competition | 1 | 2013 | 219 | 0.090 |
Why?
|
| Intraoperative Care | 3 | 2012 | 767 | 0.090 |
Why?
|
| Anticoagulants | 2 | 2024 | 4812 | 0.090 |
Why?
|
| Facial Transplantation | 1 | 2013 | 221 | 0.090 |
Why?
|
| Pregnancy Complications | 2 | 2016 | 2947 | 0.090 |
Why?
|
| Cause of Death | 5 | 2016 | 3683 | 0.090 |
Why?
|
| Sutures | 2 | 2010 | 284 | 0.090 |
Why?
|
| Fluorouracil | 8 | 2005 | 1642 | 0.090 |
Why?
|
| Health Services Research | 3 | 2019 | 1812 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 2019 | 1407 | 0.090 |
Why?
|
| Surgical Mesh | 2 | 2010 | 311 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 5 | 2018 | 5368 | 0.090 |
Why?
|
| Self Efficacy | 2 | 2014 | 638 | 0.090 |
Why?
|
| Genetic Testing | 1 | 2023 | 3537 | 0.090 |
Why?
|
| Culture | 1 | 2014 | 623 | 0.090 |
Why?
|
| Polyglactin 910 | 1 | 2010 | 55 | 0.090 |
Why?
|
| Resuscitation | 1 | 2015 | 673 | 0.090 |
Why?
|
| Androgens | 1 | 2018 | 1286 | 0.090 |
Why?
|
| Physician's Role | 1 | 2017 | 917 | 0.090 |
Why?
|
| Feasibility Studies | 6 | 2023 | 5247 | 0.090 |
Why?
|
| Mathematical Computing | 1 | 1990 | 142 | 0.090 |
Why?
|
| Axilla | 2 | 2010 | 624 | 0.090 |
Why?
|
| Renal Artery | 1 | 2012 | 351 | 0.090 |
Why?
|
| Work Schedule Tolerance | 2 | 2016 | 551 | 0.090 |
Why?
|
| Income | 6 | 2024 | 1877 | 0.090 |
Why?
|
| Rectus Abdominis | 1 | 2010 | 103 | 0.090 |
Why?
|
| Heart Failure | 6 | 2020 | 11671 | 0.090 |
Why?
|
| Pregnancy Outcome | 2 | 2019 | 2922 | 0.090 |
Why?
|
| Patient Access to Records | 1 | 2011 | 119 | 0.090 |
Why?
|
| Patient Identification Systems | 1 | 2010 | 75 | 0.090 |
Why?
|
| Models, Theoretical | 3 | 2016 | 3575 | 0.090 |
Why?
|
| Cranial Irradiation | 1 | 2012 | 390 | 0.090 |
Why?
|
| Carotid Stenosis | 1 | 2017 | 860 | 0.080 |
Why?
|
| Canada | 4 | 2019 | 2122 | 0.080 |
Why?
|
| Colposcopy | 1 | 2010 | 150 | 0.080 |
Why?
|
| Fluvoxamine | 2 | 1999 | 78 | 0.080 |
Why?
|
| Health Services for the Aged | 1 | 2012 | 259 | 0.080 |
Why?
|
| Breast Self-Examination | 1 | 2009 | 33 | 0.080 |
Why?
|
| Patient Care | 3 | 2023 | 622 | 0.080 |
Why?
|
| Endocrine System Diseases | 1 | 2012 | 249 | 0.080 |
Why?
|
| New Jersey | 1 | 2010 | 295 | 0.080 |
Why?
|
| Hospitals, Urban | 2 | 2010 | 500 | 0.080 |
Why?
|
| Phenotype | 2 | 2024 | 16592 | 0.080 |
Why?
|
| Ethylene Glycol | 1 | 2009 | 31 | 0.080 |
Why?
|
| Phlebotomy | 1 | 2010 | 137 | 0.080 |
Why?
|
| Narcotics | 1 | 2011 | 336 | 0.080 |
Why?
|
| Headache | 2 | 2021 | 1256 | 0.080 |
Why?
|
| Abdomen | 1 | 2015 | 1128 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2022 | 4028 | 0.080 |
Why?
|
| Hospitals, General | 3 | 2023 | 798 | 0.080 |
Why?
|
| Family | 5 | 2020 | 3195 | 0.080 |
Why?
|
| Evidence-Based Medicine | 5 | 2018 | 3688 | 0.080 |
Why?
|
| Hospital Bed Capacity | 1 | 2010 | 206 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2005 | 2118 | 0.080 |
Why?
|
| Cervical Vertebrae | 1 | 2015 | 980 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2012 | 1068 | 0.080 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2012 | 801 | 0.080 |
Why?
|
| Clinical Pharmacy Information Systems | 1 | 2009 | 102 | 0.080 |
Why?
|
| Case Management | 1 | 2011 | 272 | 0.080 |
Why?
|
| Insurance, Health | 2 | 2019 | 2499 | 0.080 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2010 | 214 | 0.080 |
Why?
|
| Spinal Fractures | 1 | 2015 | 705 | 0.080 |
Why?
|
| Cardiotonic Agents | 1 | 2012 | 539 | 0.080 |
Why?
|
| Body Water | 1 | 2010 | 340 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 1505 | 0.080 |
Why?
|
| Specialization | 1 | 2013 | 778 | 0.080 |
Why?
|
| Suture Techniques | 2 | 2010 | 769 | 0.080 |
Why?
|
| Random Allocation | 4 | 2022 | 2395 | 0.080 |
Why?
|
| Myocardial Infarction | 5 | 2020 | 11461 | 0.080 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 2421 | 0.080 |
Why?
|
| Risk Adjustment | 3 | 2017 | 600 | 0.080 |
Why?
|
| Emotions | 2 | 2011 | 2739 | 0.080 |
Why?
|
| Interdisciplinary Communication | 2 | 2011 | 931 | 0.080 |
Why?
|
| Mass Screening | 7 | 2021 | 5429 | 0.080 |
Why?
|
| Fees, Pharmaceutical | 1 | 2008 | 66 | 0.080 |
Why?
|
| Carcinoma | 2 | 2011 | 2330 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2007 | 1935 | 0.080 |
Why?
|
| Prognosis | 13 | 2018 | 29629 | 0.080 |
Why?
|
| Physical Fitness | 1 | 2012 | 743 | 0.080 |
Why?
|
| Burns | 1 | 2019 | 1882 | 0.080 |
Why?
|
| Hodgkin Disease | 2 | 2007 | 1378 | 0.080 |
Why?
|
| Prescription Drugs | 2 | 2019 | 631 | 0.080 |
Why?
|
| Poverty | 4 | 2023 | 2697 | 0.080 |
Why?
|
| Faculty, Medical | 3 | 2011 | 1204 | 0.070 |
Why?
|
| Device Approval | 1 | 2009 | 163 | 0.070 |
Why?
|
| Medical Informatics Applications | 1 | 2009 | 178 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 6 | 2023 | 5493 | 0.070 |
Why?
|
| Models, Biological | 5 | 2010 | 9469 | 0.070 |
Why?
|
| Pelvis | 3 | 2019 | 733 | 0.070 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2007 | 24 | 0.070 |
Why?
|
| Self Report | 3 | 2018 | 3725 | 0.070 |
Why?
|
| Costs and Cost Analysis | 4 | 2015 | 1668 | 0.070 |
Why?
|
| Tobacco Smoke Pollution | 5 | 2006 | 819 | 0.070 |
Why?
|
| Morbidity | 5 | 2017 | 1752 | 0.070 |
Why?
|
| Asthma | 3 | 2004 | 6234 | 0.070 |
Why?
|
| Consumer Health Information | 1 | 2010 | 215 | 0.070 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2009 | 264 | 0.070 |
Why?
|
| Lymph Nodes | 3 | 2017 | 3465 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2021 | 20568 | 0.070 |
Why?
|
| Arthroplasty | 1 | 2010 | 313 | 0.070 |
Why?
|
| Mortality | 4 | 2024 | 2902 | 0.070 |
Why?
|
| Face | 1 | 2013 | 1026 | 0.070 |
Why?
|
| Nursing Staff, Hospital | 1 | 2010 | 348 | 0.070 |
Why?
|
| Cross Infection | 3 | 2014 | 1422 | 0.070 |
Why?
|
| Asia | 3 | 2015 | 619 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 5314 | 0.070 |
Why?
|
| Orthopedics | 1 | 2016 | 898 | 0.070 |
Why?
|
| Troponin | 2 | 2003 | 502 | 0.070 |
Why?
|
| Troponin I | 3 | 2008 | 651 | 0.070 |
Why?
|
| Testosterone | 1 | 2018 | 2472 | 0.070 |
Why?
|
| Paintings | 1 | 2008 | 103 | 0.070 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2011 | 369 | 0.070 |
Why?
|
| Diagnostic Imaging | 2 | 2011 | 3530 | 0.070 |
Why?
|
| Israel | 3 | 2016 | 726 | 0.070 |
Why?
|
| Denmark | 3 | 2016 | 771 | 0.070 |
Why?
|
| Emergency Medicine | 1 | 2016 | 1198 | 0.070 |
Why?
|
| Interferon-alpha | 3 | 2002 | 921 | 0.070 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2011 | 350 | 0.070 |
Why?
|
| Communication Barriers | 2 | 2024 | 414 | 0.070 |
Why?
|
| Hernia, Ventral | 1 | 2010 | 218 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 3 | 2021 | 1702 | 0.070 |
Why?
|
| Blood Loss, Surgical | 4 | 2012 | 638 | 0.070 |
Why?
|
| Treatment Failure | 5 | 2015 | 2643 | 0.070 |
Why?
|
| Observation | 1 | 2008 | 310 | 0.070 |
Why?
|
| Antimetabolites, Antineoplastic | 3 | 2002 | 646 | 0.070 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2012 | 1723 | 0.070 |
Why?
|
| Prevalence | 7 | 2023 | 15733 | 0.070 |
Why?
|
| Germany | 2 | 2018 | 875 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 1866 | 0.070 |
Why?
|
| Didanosine | 2 | 2010 | 151 | 0.070 |
Why?
|
| Vitamin K | 1 | 2008 | 318 | 0.070 |
Why?
|
| Auranofin | 3 | 1999 | 16 | 0.070 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2010 | 2199 | 0.070 |
Why?
|
| Catheterization, Peripheral | 1 | 2009 | 343 | 0.070 |
Why?
|
| Cryosurgery | 1 | 2011 | 474 | 0.060 |
Why?
|
| Back Pain | 1 | 2010 | 545 | 0.060 |
Why?
|
| Head | 1 | 2012 | 924 | 0.060 |
Why?
|
| Diet | 4 | 2013 | 8075 | 0.060 |
Why?
|
| Tunica Media | 1 | 2006 | 112 | 0.060 |
Why?
|
| Insurance Claim Review | 3 | 2019 | 741 | 0.060 |
Why?
|
| Accidents, Traffic | 2 | 2021 | 816 | 0.060 |
Why?
|
| Limb Salvage | 1 | 2008 | 481 | 0.060 |
Why?
|
| Intestinal Diseases | 1 | 2010 | 504 | 0.060 |
Why?
|
| Bioprosthesis | 1 | 2010 | 591 | 0.060 |
Why?
|
| Job Satisfaction | 1 | 2009 | 544 | 0.060 |
Why?
|
| New York | 6 | 2020 | 874 | 0.060 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2010 | 499 | 0.060 |
Why?
|
| Nurse Practitioners | 2 | 2024 | 271 | 0.060 |
Why?
|
| Emergency Medical Services | 3 | 2012 | 1923 | 0.060 |
Why?
|
| Diagnosis-Related Groups | 2 | 2019 | 449 | 0.060 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2009 | 748 | 0.060 |
Why?
|
| Stents | 1 | 2017 | 3179 | 0.060 |
Why?
|
| Teaching | 1 | 2013 | 1170 | 0.060 |
Why?
|
| Severity of Illness Index | 6 | 2020 | 15843 | 0.060 |
Why?
|
| Energy Intake | 1 | 2013 | 2134 | 0.060 |
Why?
|
| Comprehension | 1 | 2010 | 621 | 0.060 |
Why?
|
| Disease | 1 | 2010 | 672 | 0.060 |
Why?
|
| Patient Preference | 2 | 2024 | 927 | 0.060 |
Why?
|
| Neurosurgical Procedures | 2 | 2020 | 2072 | 0.060 |
Why?
|
| Sensitivity and Specificity | 9 | 2015 | 14665 | 0.060 |
Why?
|
| Angioplasty | 1 | 2007 | 355 | 0.060 |
Why?
|
| Cognition | 2 | 2023 | 6992 | 0.060 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2018 | 1875 | 0.060 |
Why?
|
| Workflow | 3 | 2016 | 851 | 0.060 |
Why?
|
| Rural Health Services | 2 | 2019 | 384 | 0.060 |
Why?
|
| Melanoma | 2 | 2019 | 5709 | 0.060 |
Why?
|
| Heart Valve Diseases | 2 | 2010 | 1027 | 0.060 |
Why?
|
| Enalapril | 2 | 2005 | 312 | 0.060 |
Why?
|
| Demography | 3 | 2018 | 1648 | 0.060 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2024 | 78 | 0.060 |
Why?
|
| Arsenic | 2 | 1998 | 362 | 0.060 |
Why?
|
| Workplace | 1 | 2011 | 863 | 0.060 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2008 | 517 | 0.060 |
Why?
|
| Body Composition | 2 | 2013 | 2426 | 0.060 |
Why?
|
| Perioperative Care | 2 | 2024 | 1036 | 0.060 |
Why?
|
| Rural Health | 1 | 2006 | 296 | 0.060 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2007 | 537 | 0.060 |
Why?
|
| Schizophrenia | 2 | 2011 | 6937 | 0.060 |
Why?
|
| Hospitals, University | 4 | 2009 | 564 | 0.060 |
Why?
|
| Chest Pain | 2 | 2021 | 1091 | 0.060 |
Why?
|
| Zidovudine | 2 | 2010 | 624 | 0.060 |
Why?
|
| Streptozocin | 3 | 2007 | 194 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2017 | 9319 | 0.060 |
Why?
|
| Caffeine | 1 | 2008 | 700 | 0.060 |
Why?
|
| Water Pollutants, Chemical | 2 | 1998 | 359 | 0.060 |
Why?
|
| Hemoglobins | 3 | 2011 | 1526 | 0.060 |
Why?
|
| Evidence-Based Practice | 2 | 2020 | 495 | 0.060 |
Why?
|
| Informed Consent | 1 | 2010 | 1008 | 0.060 |
Why?
|
| Amputees | 1 | 2024 | 91 | 0.060 |
Why?
|
| Ubiquinone | 1 | 2005 | 183 | 0.060 |
Why?
|
| Tunica Intima | 1 | 2006 | 459 | 0.060 |
Why?
|
| Carcinoid Tumor | 1 | 2005 | 224 | 0.060 |
Why?
|
| Tricuspid Valve | 1 | 2006 | 410 | 0.060 |
Why?
|
| Thoracic Surgery | 1 | 2010 | 722 | 0.060 |
Why?
|
| Mathematics | 2 | 1995 | 707 | 0.050 |
Why?
|
| Control Groups | 1 | 2023 | 104 | 0.050 |
Why?
|
| Risk Management | 1 | 2007 | 558 | 0.050 |
Why?
|
| Respiratory-Gated Imaging Techniques | 1 | 2024 | 75 | 0.050 |
Why?
|
| Medicare Part D | 1 | 2008 | 355 | 0.050 |
Why?
|
| Hyperglycemia | 2 | 2010 | 1376 | 0.050 |
Why?
|
| Physicians, Women | 1 | 2009 | 509 | 0.050 |
Why?
|
| Diabetic Foot | 1 | 2007 | 380 | 0.050 |
Why?
|
| Learning | 1 | 2013 | 1740 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2008 | 746 | 0.050 |
Why?
|
| Cholesterol | 3 | 2012 | 2905 | 0.050 |
Why?
|
| Carotid Artery, Internal | 1 | 2006 | 445 | 0.050 |
Why?
|
| Audiovisual Aids | 1 | 2024 | 99 | 0.050 |
Why?
|
| Polymers | 1 | 2010 | 1616 | 0.050 |
Why?
|
| Mediastinum | 1 | 2004 | 266 | 0.050 |
Why?
|
| Liver Cirrhosis, Biliary | 2 | 2005 | 108 | 0.050 |
Why?
|
| Educational Status | 4 | 2016 | 2522 | 0.050 |
Why?
|
| Cystatin C | 1 | 2024 | 270 | 0.050 |
Why?
|
| Clostridium Infections | 1 | 2009 | 558 | 0.050 |
Why?
|
| Sleep Deprivation | 1 | 2009 | 846 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 2 | 2023 | 935 | 0.050 |
Why?
|
| Space Simulation | 1 | 2022 | 9 | 0.050 |
Why?
|
| Isoenzymes | 3 | 2003 | 1687 | 0.050 |
Why?
|
| Vitamin A | 3 | 1996 | 613 | 0.050 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2006 | 353 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2012 | 5112 | 0.050 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2022 | 162 | 0.050 |
Why?
|
| User-Computer Interface | 2 | 2019 | 1400 | 0.050 |
Why?
|
| Uncertainty | 1 | 2007 | 754 | 0.050 |
Why?
|
| Blood Cell Count | 1 | 2023 | 397 | 0.050 |
Why?
|
| Infection Control | 1 | 2009 | 982 | 0.050 |
Why?
|
| Lung | 4 | 2024 | 10002 | 0.050 |
Why?
|
| Uremia | 1 | 2003 | 201 | 0.050 |
Why?
|
| Myocytes, Cardiac | 2 | 2008 | 1668 | 0.050 |
Why?
|
| Parturition | 2 | 2018 | 448 | 0.050 |
Why?
|
| Anus Neoplasms | 2 | 1996 | 329 | 0.050 |
Why?
|
| Physical Examination | 1 | 2008 | 1255 | 0.050 |
Why?
|
| Africa | 2 | 2015 | 709 | 0.050 |
Why?
|
| Personal Autonomy | 1 | 2024 | 304 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 3 | 2008 | 1625 | 0.050 |
Why?
|
| Colonoscopy | 2 | 2021 | 1394 | 0.050 |
Why?
|
| Mothers | 4 | 2006 | 2198 | 0.050 |
Why?
|
| Organizational Case Studies | 2 | 2014 | 301 | 0.050 |
Why?
|
| Observer Variation | 2 | 2020 | 2606 | 0.050 |
Why?
|
| Reoperation | 5 | 2010 | 4303 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2010 | 1126 | 0.050 |
Why?
|
| Social Support | 1 | 2011 | 2172 | 0.050 |
Why?
|
| Geriatric Assessment | 2 | 2020 | 1410 | 0.050 |
Why?
|
| Biocompatible Materials | 1 | 2010 | 1685 | 0.050 |
Why?
|
| Penile Erection | 2 | 2012 | 100 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 1 | 2010 | 1462 | 0.050 |
Why?
|
| Creatine Kinase, MB Form | 3 | 2008 | 202 | 0.050 |
Why?
|
| Standard of Care | 2 | 2017 | 551 | 0.050 |
Why?
|
| HIV Infections | 4 | 2015 | 17354 | 0.050 |
Why?
|
| Cachexia | 1 | 2023 | 202 | 0.050 |
Why?
|
| Tenascin | 1 | 2001 | 62 | 0.050 |
Why?
|
| Stomach Diseases | 1 | 2002 | 134 | 0.050 |
Why?
|
| Perineum | 2 | 2014 | 208 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7406 | 0.050 |
Why?
|
| Evidence-Based Nursing | 1 | 2020 | 14 | 0.050 |
Why?
|
| Drug Administration Schedule | 5 | 2012 | 4853 | 0.050 |
Why?
|
| Safety | 3 | 2014 | 1149 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2006 | 881 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 4878 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2007 | 1119 | 0.050 |
Why?
|
| Diabetic Angiopathies | 1 | 2006 | 803 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2011 | 2629 | 0.050 |
Why?
|
| Cost of Illness | 2 | 2023 | 1937 | 0.050 |
Why?
|
| Ablation Techniques | 1 | 2023 | 248 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2008 | 1808 | 0.050 |
Why?
|
| Utah | 2 | 2016 | 131 | 0.050 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2005 | 536 | 0.040 |
Why?
|
| North America | 2 | 2018 | 1276 | 0.040 |
Why?
|
| Cholesterol, HDL | 2 | 2006 | 1814 | 0.040 |
Why?
|
| Disease Management | 2 | 2024 | 2508 | 0.040 |
Why?
|
| Environment Design | 1 | 2022 | 173 | 0.040 |
Why?
|
| California | 1 | 2024 | 1430 | 0.040 |
Why?
|
| Human Growth Hormone | 1 | 2005 | 642 | 0.040 |
Why?
|
| Cholesterol, LDL | 3 | 2006 | 2382 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2007 | 973 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2010 | 1955 | 0.040 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2023 | 461 | 0.040 |
Why?
|
| Anti-HIV Agents | 2 | 2010 | 4527 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 4062 | 0.040 |
Why?
|
| Trimetrexate | 1 | 1999 | 15 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 1096 | 0.040 |
Why?
|
| American Cancer Society | 1 | 2019 | 69 | 0.040 |
Why?
|
| Heart-Assist Devices | 1 | 2010 | 1287 | 0.040 |
Why?
|
| Disulfiram | 1 | 2020 | 63 | 0.040 |
Why?
|
| Topotecan | 1 | 2000 | 132 | 0.040 |
Why?
|
| Germ Cells | 1 | 2023 | 634 | 0.040 |
Why?
|
| Smoke Inhalation Injury | 1 | 2019 | 47 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2005 | 1516 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2007 | 2665 | 0.040 |
Why?
|
| Urination Disorders | 2 | 2011 | 238 | 0.040 |
Why?
|
| Needs Assessment | 2 | 2018 | 1139 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2023 | 617 | 0.040 |
Why?
|
| Narcotic Antagonists | 1 | 2024 | 585 | 0.040 |
Why?
|
| Albumins | 1 | 2022 | 575 | 0.040 |
Why?
|
| Harringtonines | 1 | 1999 | 8 | 0.040 |
Why?
|
| Serum Albumin | 2 | 2016 | 672 | 0.040 |
Why?
|
| Neoplasms, Second Primary | 1 | 2007 | 1052 | 0.040 |
Why?
|
| Single-Blind Method | 2 | 2014 | 1574 | 0.040 |
Why?
|
| Birth Certificates | 1 | 2019 | 71 | 0.040 |
Why?
|
| Cholinergic Antagonists | 1 | 2020 | 168 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2009 | 1935 | 0.040 |
Why?
|
| Myocardial Contraction | 4 | 2010 | 1515 | 0.040 |
Why?
|
| Scotland | 1 | 2019 | 143 | 0.040 |
Why?
|
| Gait | 1 | 2024 | 814 | 0.040 |
Why?
|
| Language | 2 | 2024 | 1543 | 0.040 |
Why?
|
| Technology | 1 | 2021 | 292 | 0.040 |
Why?
|
| Helicobacter pylori | 1 | 2002 | 377 | 0.040 |
Why?
|
| C-Reactive Protein | 4 | 2012 | 3826 | 0.040 |
Why?
|
| Birth Weight | 2 | 2023 | 2103 | 0.040 |
Why?
|
| Helicobacter Infections | 1 | 2002 | 388 | 0.040 |
Why?
|
| Gentamicins | 1 | 2019 | 243 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2023 | 644 | 0.040 |
Why?
|
| Stomach Neoplasms | 2 | 1999 | 1459 | 0.040 |
Why?
|
| Fresh Water | 1 | 1998 | 82 | 0.040 |
Why?
|
| Iatrogenic Disease | 2 | 1992 | 540 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2023 | 787 | 0.040 |
Why?
|
| Health Policy | 1 | 2011 | 2684 | 0.040 |
Why?
|
| Philosophy, Medical | 1 | 1998 | 79 | 0.040 |
Why?
|
| Minocycline | 1 | 2019 | 169 | 0.040 |
Why?
|
| Acinetobacter baumannii | 1 | 2019 | 118 | 0.040 |
Why?
|
| Histological Techniques | 1 | 2019 | 194 | 0.040 |
Why?
|
| Obesity | 4 | 2022 | 12947 | 0.040 |
Why?
|
| Clavicle | 1 | 2020 | 224 | 0.040 |
Why?
|
| gamma-Globulins | 1 | 1998 | 119 | 0.040 |
Why?
|
| Alginates | 1 | 2019 | 248 | 0.040 |
Why?
|
| Faculty | 1 | 2021 | 384 | 0.040 |
Why?
|
| Esophagoscopy | 1 | 2020 | 396 | 0.040 |
Why?
|
| Primary Nursing | 1 | 2017 | 10 | 0.040 |
Why?
|
| Rural Population | 4 | 2017 | 2287 | 0.040 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2019 | 124 | 0.040 |
Why?
|
| Men's Health | 1 | 2018 | 73 | 0.040 |
Why?
|
| Catheter Ablation | 1 | 2011 | 2751 | 0.040 |
Why?
|
| Interviews as Topic | 2 | 2017 | 2696 | 0.040 |
Why?
|
| Motivation | 2 | 2022 | 2006 | 0.040 |
Why?
|
| Hydroxyurea | 1 | 1999 | 284 | 0.040 |
Why?
|
| Mental Health Services | 2 | 2019 | 1730 | 0.040 |
Why?
|
| Jaundice | 1 | 1998 | 94 | 0.040 |
Why?
|
| Intestinal Neoplasms | 2 | 2010 | 314 | 0.040 |
Why?
|
| Respiration | 1 | 2024 | 1656 | 0.040 |
Why?
|
| Models, Economic | 2 | 2012 | 716 | 0.040 |
Why?
|
| Walking | 1 | 2024 | 1198 | 0.040 |
Why?
|
| Scleroderma, Systemic | 1 | 2001 | 344 | 0.040 |
Why?
|
| Aging | 1 | 2016 | 8710 | 0.040 |
Why?
|
| Organizational Innovation | 2 | 2011 | 537 | 0.040 |
Why?
|
| Blood Urea Nitrogen | 2 | 2010 | 186 | 0.040 |
Why?
|
| Creatine Kinase | 3 | 2006 | 685 | 0.040 |
Why?
|
| Equipment Design | 2 | 2019 | 3511 | 0.040 |
Why?
|
| Poisons | 1 | 1997 | 38 | 0.040 |
Why?
|
| Myoglobin | 2 | 2008 | 159 | 0.040 |
Why?
|
| Subacute Care | 1 | 2019 | 179 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2019 | 999 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2008 | 6391 | 0.030 |
Why?
|
| Calcinosis | 1 | 2005 | 1469 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 2004 | 834 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2002 | 1154 | 0.030 |
Why?
|
| Eye Color | 1 | 1996 | 36 | 0.030 |
Why?
|
| Shock, Hemorrhagic | 1 | 2018 | 223 | 0.030 |
Why?
|
| Mexico | 1 | 2019 | 764 | 0.030 |
Why?
|
| Government Agencies | 1 | 2017 | 160 | 0.030 |
Why?
|
| Inappropriate Prescribing | 1 | 2019 | 211 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2017 | 413 | 0.030 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2006 | 1428 | 0.030 |
Why?
|
| Vancomycin | 1 | 2019 | 503 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 2001 | 1202 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2002 | 1469 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2017 | 212 | 0.030 |
Why?
|
| Family Planning Services | 1 | 2019 | 268 | 0.030 |
Why?
|
| Postnatal Care | 1 | 2018 | 262 | 0.030 |
Why?
|
| Drug Therapy | 1 | 1999 | 503 | 0.030 |
Why?
|
| Skin | 1 | 2010 | 4484 | 0.030 |
Why?
|
| Genes, ras | 1 | 1999 | 654 | 0.030 |
Why?
|
| Acute Disease | 2 | 2020 | 7237 | 0.030 |
Why?
|
| Spouses | 1 | 2018 | 283 | 0.030 |
Why?
|
| Vermont | 1 | 2016 | 81 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2011 | 4481 | 0.030 |
Why?
|
| Menogaril | 1 | 1995 | 4 | 0.030 |
Why?
|
| Oceania | 1 | 2015 | 16 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6484 | 0.030 |
Why?
|
| Ethanol | 1 | 2022 | 1324 | 0.030 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2002 | 829 | 0.030 |
Why?
|
| Cuba | 1 | 2015 | 48 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2004 | 1250 | 0.030 |
Why?
|
| Self Care | 1 | 2021 | 796 | 0.030 |
Why?
|
| Haiti | 1 | 2017 | 550 | 0.030 |
Why?
|
| Self-Assessment | 1 | 2018 | 397 | 0.030 |
Why?
|
| Life Tables | 1 | 1996 | 364 | 0.030 |
Why?
|
| Americas | 1 | 2015 | 111 | 0.030 |
Why?
|
| Moldova | 1 | 2015 | 14 | 0.030 |
Why?
|
| Precancerous Conditions | 1 | 2002 | 980 | 0.030 |
Why?
|
| Ultrasonography | 5 | 2010 | 5971 | 0.030 |
Why?
|
| Costa Rica | 1 | 2015 | 180 | 0.030 |
Why?
|
| Laboratories, Hospital | 1 | 2017 | 192 | 0.030 |
Why?
|
| Gastrostomy | 1 | 2018 | 323 | 0.030 |
Why?
|
| Bleomycin | 1 | 1996 | 494 | 0.030 |
Why?
|
| Health Care Rationing | 1 | 1998 | 437 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 2002 | 1141 | 0.030 |
Why?
|
| Artifacts | 1 | 2024 | 1911 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2019 | 1555 | 0.030 |
Why?
|
| Pain | 2 | 2023 | 5073 | 0.030 |
Why?
|
| Respiratory Tract Diseases | 2 | 2002 | 750 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2020 | 765 | 0.030 |
Why?
|
| Death | 1 | 2020 | 676 | 0.030 |
Why?
|
| Michigan | 1 | 2016 | 339 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2022 | 1265 | 0.030 |
Why?
|
| Oligonucleotides | 2 | 2008 | 582 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 2016 | 218 | 0.030 |
Why?
|
| Community Health Services | 1 | 2000 | 656 | 0.030 |
Why?
|
| Vascular Patency | 2 | 2008 | 911 | 0.030 |
Why?
|
| Fetal Death | 1 | 2016 | 435 | 0.030 |
Why?
|
| Radiotherapy Dosage | 2 | 2016 | 2898 | 0.030 |
Why?
|
| Puerperal Disorders | 1 | 2017 | 300 | 0.030 |
Why?
|
| Women's Health | 3 | 2009 | 2065 | 0.030 |
Why?
|
| Chile | 1 | 2015 | 256 | 0.030 |
Why?
|
| Cocaine | 1 | 2020 | 958 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 510 | 0.030 |
Why?
|
| Wound Healing | 2 | 2019 | 2805 | 0.030 |
Why?
|
| Health Personnel | 2 | 2023 | 3335 | 0.030 |
Why?
|
| Systems Integration | 1 | 2016 | 426 | 0.030 |
Why?
|
| Critical Pathways | 1 | 2018 | 474 | 0.030 |
Why?
|
| Obstetrics | 2 | 2013 | 666 | 0.030 |
Why?
|
| Time | 1 | 2016 | 546 | 0.030 |
Why?
|
| China | 2 | 2015 | 2374 | 0.030 |
Why?
|
| Direct Service Costs | 1 | 2014 | 59 | 0.030 |
Why?
|
| Hydrogels | 1 | 2019 | 720 | 0.030 |
Why?
|
| Ribavirin | 1 | 1996 | 395 | 0.030 |
Why?
|
| Xerophthalmia | 1 | 1993 | 12 | 0.030 |
Why?
|
| Nursing Records | 1 | 2013 | 30 | 0.030 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2014 | 56 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 847 | 0.030 |
Why?
|
| El Salvador | 1 | 2013 | 32 | 0.030 |
Why?
|
| Vitamin A Deficiency | 1 | 1994 | 88 | 0.030 |
Why?
|
| Osteosarcoma | 2 | 1996 | 897 | 0.030 |
Why?
|
| Vital Statistics | 1 | 2013 | 31 | 0.030 |
Why?
|
| Nursing Informatics | 1 | 2013 | 46 | 0.030 |
Why?
|
| Exercise | 2 | 2020 | 5890 | 0.030 |
Why?
|
| Interferon-beta | 1 | 1995 | 345 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 2079 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2019 | 1936 | 0.030 |
Why?
|
| Biopsy | 2 | 2019 | 6766 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2023 | 2107 | 0.030 |
Why?
|
| Colon | 1 | 2021 | 1792 | 0.030 |
Why?
|
| Graft Rejection | 2 | 2010 | 4446 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2015 | 551 | 0.030 |
Why?
|
| Disease Progression | 4 | 2006 | 13510 | 0.030 |
Why?
|
| Feedback, Psychological | 1 | 2012 | 96 | 0.030 |
Why?
|
| Information Systems | 1 | 2014 | 396 | 0.030 |
Why?
|
| France | 1 | 2013 | 497 | 0.030 |
Why?
|
| Myocardium | 2 | 2012 | 4725 | 0.030 |
Why?
|
| Adenoma, Islet Cell | 1 | 1992 | 72 | 0.030 |
Why?
|
| Constriction | 1 | 2012 | 168 | 0.020 |
Why?
|
| Curriculum | 2 | 2017 | 3743 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2017 | 857 | 0.020 |
Why?
|
| Reimbursement, Incentive | 1 | 2017 | 543 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 2720 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2019 | 1277 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2017 | 909 | 0.020 |
Why?
|
| Live Birth | 1 | 2015 | 511 | 0.020 |
Why?
|
| Acetazolamide | 1 | 1992 | 96 | 0.020 |
Why?
|
| Decision Making | 2 | 2016 | 3929 | 0.020 |
Why?
|
| Perphenazine | 1 | 2011 | 33 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2019 | 1457 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 10766 | 0.020 |
Why?
|
| Inflammation | 1 | 2011 | 10774 | 0.020 |
Why?
|
| Hospital Departments | 1 | 2011 | 134 | 0.020 |
Why?
|
| Societies, Medical | 2 | 2016 | 3905 | 0.020 |
Why?
|
| Anesthesia Department, Hospital | 1 | 2011 | 69 | 0.020 |
Why?
|
| Lipids | 1 | 2022 | 3341 | 0.020 |
Why?
|
| Exercise Test | 2 | 2012 | 2127 | 0.020 |
Why?
|
| Malignant Hyperthermia | 1 | 2011 | 71 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2006 | 3415 | 0.020 |
Why?
|
| Economics, Hospital | 1 | 1993 | 210 | 0.020 |
Why?
|
| Affect | 1 | 1999 | 1486 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2005 | 2877 | 0.020 |
Why?
|
| Nursing Methodology Research | 1 | 2010 | 64 | 0.020 |
Why?
|
| Ownership | 1 | 2013 | 339 | 0.020 |
Why?
|
| Dibenzothiazepines | 1 | 2011 | 102 | 0.020 |
Why?
|
| Embolism, Air | 1 | 2011 | 110 | 0.020 |
Why?
|
| Personality | 1 | 2014 | 554 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1995 | 621 | 0.020 |
Why?
|
| Organizational Culture | 1 | 2014 | 509 | 0.020 |
Why?
|
| Animals | 7 | 2023 | 168475 | 0.020 |
Why?
|
| Awareness | 1 | 2015 | 648 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2012 | 297 | 0.020 |
Why?
|
| Reference Values | 2 | 2009 | 4920 | 0.020 |
Why?
|
| Coronary Artery Disease | 2 | 2012 | 6403 | 0.020 |
Why?
|
| Fat Necrosis | 1 | 2010 | 60 | 0.020 |
Why?
|
| Role Playing | 1 | 2010 | 22 | 0.020 |
Why?
|
| Mitomycin | 2 | 2005 | 263 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 1996 | 2220 | 0.020 |
Why?
|
| Africa, Northern | 1 | 2010 | 86 | 0.020 |
Why?
|
| Photography | 1 | 2013 | 532 | 0.020 |
Why?
|
| Heart Transplantation | 2 | 2002 | 3233 | 0.020 |
Why?
|
| Liability, Legal | 1 | 1992 | 210 | 0.020 |
Why?
|
| Urban Population | 2 | 2009 | 2036 | 0.020 |
Why?
|
| Epigastric Arteries | 1 | 2010 | 92 | 0.020 |
Why?
|
| Transferrin | 1 | 2011 | 283 | 0.020 |
Why?
|
| Social Class | 2 | 2016 | 2004 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 3 | 1999 | 3763 | 0.020 |
Why?
|
| Endoscopy | 1 | 2020 | 1851 | 0.020 |
Why?
|
| Software Design | 1 | 1990 | 171 | 0.020 |
Why?
|
| Housekeeping, Hospital | 1 | 2009 | 17 | 0.020 |
Why?
|
| Double-Blind Method | 3 | 2010 | 12341 | 0.020 |
Why?
|
| Utilization Review | 1 | 2011 | 382 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 3124 | 0.020 |
Why?
|
| Swine | 1 | 2019 | 5915 | 0.020 |
Why?
|
| Middle East | 1 | 2010 | 231 | 0.020 |
Why?
|
| New Zealand | 1 | 2010 | 358 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2012 | 679 | 0.020 |
Why?
|
| Ligation | 1 | 2010 | 448 | 0.020 |
Why?
|
| Urinary Catheterization | 1 | 2010 | 193 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 2016 | 940 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 802 | 0.020 |
Why?
|
| Hernia, Abdominal | 1 | 2010 | 56 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2011 | 395 | 0.020 |
Why?
|
| Mental Disorders | 2 | 1999 | 6845 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2013 | 627 | 0.020 |
Why?
|
| Specialty Boards | 1 | 2011 | 235 | 0.020 |
Why?
|
| Traction | 1 | 2009 | 110 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2010 | 376 | 0.020 |
Why?
|
| Radiography | 2 | 2011 | 6965 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2002 | 3810 | 0.020 |
Why?
|
| Students, Medical | 2 | 2014 | 1936 | 0.020 |
Why?
|
| Diastole | 2 | 2002 | 782 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 1664 | 0.020 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 1 | 2009 | 92 | 0.020 |
Why?
|
| Switzerland | 1 | 2009 | 324 | 0.020 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 1992 | 339 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 1200 | 0.020 |
Why?
|
| Vocal Cord Paralysis | 1 | 2012 | 272 | 0.020 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2010 | 103 | 0.020 |
Why?
|
| Tissue Expansion Devices | 1 | 2010 | 156 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2010 | 1157 | 0.020 |
Why?
|
| Latin America | 1 | 2010 | 410 | 0.020 |
Why?
|
| ROC Curve | 2 | 2011 | 3578 | 0.020 |
Why?
|
| Organizational Policy | 1 | 2011 | 432 | 0.020 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2005 | 851 | 0.020 |
Why?
|
| Poverty Areas | 1 | 2010 | 263 | 0.020 |
Why?
|
| Group Processes | 1 | 2010 | 228 | 0.020 |
Why?
|
| Breast | 1 | 2017 | 1967 | 0.020 |
Why?
|
| Europe | 1 | 2015 | 3420 | 0.020 |
Why?
|
| Age of Onset | 2 | 2011 | 3306 | 0.020 |
Why?
|
| Self Disclosure | 1 | 2009 | 249 | 0.020 |
Why?
|
| Apgar Score | 1 | 2008 | 126 | 0.020 |
Why?
|
| Program Development | 1 | 2014 | 1297 | 0.020 |
Why?
|
| Anxiety | 1 | 2023 | 4573 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 1241 | 0.020 |
Why?
|
| Medically Underserved Area | 1 | 2010 | 254 | 0.020 |
Why?
|
| Disclosure | 1 | 2014 | 748 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2015 | 1352 | 0.020 |
Why?
|
| Dissection | 1 | 2009 | 298 | 0.020 |
Why?
|
| Health Plan Implementation | 1 | 2011 | 337 | 0.020 |
Why?
|
| Spinal Cord Injuries | 1 | 2015 | 925 | 0.020 |
Why?
|
| Licensure, Medical | 1 | 2008 | 71 | 0.020 |
Why?
|
| Marriage | 1 | 2009 | 351 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 2014 | 929 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2007 | 60 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 2014 | 1474 | 0.020 |
Why?
|
| Africa South of the Sahara | 1 | 2010 | 744 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2017 | 1909 | 0.020 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2011 | 357 | 0.020 |
Why?
|
| Mass Media | 1 | 2010 | 303 | 0.020 |
Why?
|
| Parenteral Nutrition | 1 | 2012 | 659 | 0.020 |
Why?
|
| Policy Making | 1 | 2011 | 542 | 0.020 |
Why?
|
| Developed Countries | 1 | 2010 | 449 | 0.020 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2007 | 92 | 0.020 |
Why?
|
| Paclitaxel | 1 | 1995 | 1732 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 1112 | 0.020 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2009 | 292 | 0.020 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1995 | 954 | 0.020 |
Why?
|
| Home Care Services | 1 | 2013 | 648 | 0.020 |
Why?
|
| Hormones | 1 | 2011 | 869 | 0.020 |
Why?
|
| Negotiating | 1 | 2008 | 150 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2007 | 198 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2010 | 983 | 0.020 |
Why?
|
| Taiwan | 2 | 1998 | 521 | 0.020 |
Why?
|
| Gestational Age | 1 | 2015 | 3577 | 0.020 |
Why?
|
| Wisconsin | 1 | 2006 | 122 | 0.020 |
Why?
|
| Seizures | 1 | 2019 | 2957 | 0.020 |
Why?
|
| Physician Assistants | 1 | 2009 | 191 | 0.020 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2008 | 189 | 0.020 |
Why?
|
| Scientific Misconduct | 1 | 2007 | 74 | 0.020 |
Why?
|
| Australia | 1 | 2010 | 1250 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 2012 | 908 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2013 | 1738 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2008 | 4160 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2013 | 1530 | 0.020 |
Why?
|
| Recurrence | 2 | 2010 | 8466 | 0.020 |
Why?
|
| Breast Implants | 1 | 2010 | 411 | 0.020 |
Why?
|
| Hospitals, Private | 1 | 2006 | 63 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 2010 | 697 | 0.020 |
Why?
|
| Counseling | 1 | 2014 | 1547 | 0.020 |
Why?
|
| Necrosis | 1 | 2010 | 1611 | 0.020 |
Why?
|
| Urologic Surgical Procedures | 1 | 2008 | 298 | 0.020 |
Why?
|
| Models, Educational | 1 | 2008 | 373 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2010 | 757 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2010 | 617 | 0.020 |
Why?
|
| Pericardium | 1 | 2010 | 675 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2010 | 702 | 0.020 |
Why?
|
| Accreditation | 1 | 2008 | 473 | 0.020 |
Why?
|
| Penicillamine | 1 | 2005 | 60 | 0.020 |
Why?
|
| Body Temperature | 1 | 2008 | 781 | 0.020 |
Why?
|
| Social Environment | 1 | 2010 | 1020 | 0.020 |
Why?
|
| Memory | 1 | 2014 | 2193 | 0.020 |
Why?
|
| Anesthesia | 1 | 2016 | 1595 | 0.010 |
Why?
|
| Focus Groups | 1 | 2010 | 1415 | 0.010 |
Why?
|
| Heart Rate | 2 | 2008 | 4195 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 2010 | 1204 | 0.010 |
Why?
|
| Catheterization, Central Venous | 1 | 2009 | 526 | 0.010 |
Why?
|
| Device Removal | 1 | 2009 | 630 | 0.010 |
Why?
|
| Cervix Uteri | 1 | 2008 | 570 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2007 | 449 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2000 | 4024 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 2006 | 510 | 0.010 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2004 | 61 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1996 | 2529 | 0.010 |
Why?
|
| Catheterization | 1 | 2009 | 1428 | 0.010 |
Why?
|
| Health Literacy | 1 | 2009 | 444 | 0.010 |
Why?
|
| Tissue Scaffolds | 1 | 2010 | 934 | 0.010 |
Why?
|
| Sudan | 2 | 1994 | 86 | 0.010 |
Why?
|
| Anaphylaxis | 1 | 2011 | 757 | 0.010 |
Why?
|
| Mice | 4 | 2009 | 81539 | 0.010 |
Why?
|
| Geography | 1 | 2006 | 656 | 0.010 |
Why?
|
| Gynecology | 1 | 2009 | 526 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 1998 | 4485 | 0.010 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2007 | 494 | 0.010 |
Why?
|
| Hypopituitarism | 1 | 2005 | 250 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 1379 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2006 | 1704 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2015 | 2151 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1995 | 2297 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 2006 | 642 | 0.010 |
Why?
|
| Heart Block | 1 | 2004 | 386 | 0.010 |
Why?
|
| Chelating Agents | 1 | 2004 | 387 | 0.010 |
Why?
|
| Japan | 1 | 2007 | 1378 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 2007 | 737 | 0.010 |
Why?
|
| Floxuridine | 1 | 2002 | 44 | 0.010 |
Why?
|
| Mental Recall | 1 | 2009 | 1221 | 0.010 |
Why?
|
| Hospital Records | 2 | 1993 | 93 | 0.010 |
Why?
|
| Medicine | 1 | 2010 | 942 | 0.010 |
Why?
|
| Hypotension | 1 | 2008 | 879 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 1626 | 0.010 |
Why?
|
| Fatigue | 1 | 2009 | 1552 | 0.010 |
Why?
|
| Colorado | 1 | 2002 | 165 | 0.010 |
Why?
|
| Peritoneal Dialysis | 1 | 2003 | 159 | 0.010 |
Why?
|
| Low Back Pain | 1 | 2010 | 984 | 0.010 |
Why?
|
| Tachycardia | 1 | 2004 | 600 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2002 | 221 | 0.010 |
Why?
|
| International Classification of Diseases | 1 | 2007 | 910 | 0.010 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2001 | 43 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2017 | 3429 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2008 | 1347 | 0.010 |
Why?
|
| Hyperparathyroidism | 1 | 2003 | 337 | 0.010 |
Why?
|
| Thorax | 1 | 2004 | 555 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2007 | 1475 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 1999 | 5146 | 0.010 |
Why?
|
| Hepatic Artery | 1 | 2002 | 232 | 0.010 |
Why?
|
| Anthropometry | 1 | 2005 | 1349 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2010 | 2332 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2006 | 1086 | 0.010 |
Why?
|
| Anemia | 1 | 2010 | 1509 | 0.010 |
Why?
|
| Cisplatin | 2 | 1996 | 1652 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1651 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 1122 | 0.010 |
Why?
|
| Patient Transfer | 1 | 2007 | 794 | 0.010 |
Why?
|
| Graft Survival | 1 | 2010 | 3820 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2010 | 3551 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 1545 | 0.010 |
Why?
|
| Pediatrics | 1 | 2014 | 3589 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1998 | 5821 | 0.010 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2008 | 1070 | 0.010 |
Why?
|
| Agranulocytosis | 1 | 1999 | 97 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2001 | 755 | 0.010 |
Why?
|
| Placebos | 1 | 2003 | 1667 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 2004 | 1007 | 0.010 |
Why?
|
| Body Height | 1 | 2005 | 1570 | 0.010 |
Why?
|
| Epidemiologic Research Design | 1 | 2002 | 368 | 0.010 |
Why?
|
| Thrombin | 1 | 2001 | 591 | 0.010 |
Why?
|
| Genotype | 1 | 2013 | 12990 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 1699 | 0.010 |
Why?
|
| Connecticut | 1 | 1999 | 364 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2001 | 461 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2010 | 3313 | 0.010 |
Why?
|
| Triglycerides | 1 | 2006 | 2461 | 0.010 |
Why?
|
| Electrocardiography | 2 | 2004 | 6377 | 0.010 |
Why?
|
| Antibodies | 1 | 2006 | 2418 | 0.010 |
Why?
|
| Life Style | 1 | 2009 | 3917 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 2011 | 3067 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2006 | 3627 | 0.010 |
Why?
|
| Weight Loss | 1 | 2009 | 2684 | 0.010 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2007 | 1394 | 0.010 |
Why?
|
| Patient Dropouts | 1 | 1999 | 412 | 0.010 |
Why?
|
| Codon | 1 | 1999 | 601 | 0.010 |
Why?
|
| Urbanization | 1 | 1997 | 100 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 2004 | 1010 | 0.010 |
Why?
|
| Leucovorin | 1 | 1999 | 643 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 12149 | 0.010 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 1996 | 94 | 0.010 |
Why?
|
| Total Lung Capacity | 1 | 1996 | 149 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1996 | 304 | 0.010 |
Why?
|
| Stomatitis | 1 | 1999 | 271 | 0.010 |
Why?
|
| Overweight | 1 | 2007 | 2417 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1996 | 411 | 0.010 |
Why?
|
| Nutritional Status | 2 | 1994 | 1615 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1996 | 416 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 11076 | 0.010 |
Why?
|
| Fever | 1 | 2002 | 1618 | 0.010 |
Why?
|
| Rats | 1 | 2010 | 23741 | 0.010 |
Why?
|
| Mutation | 1 | 1999 | 30053 | 0.010 |
Why?
|
| Medical Indigency | 1 | 1993 | 63 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2003 | 1796 | 0.010 |
Why?
|
| Sleep | 1 | 2009 | 4768 | 0.010 |
Why?
|
| Financial Management, Hospital | 1 | 1993 | 70 | 0.010 |
Why?
|
| Air Pollutants | 1 | 2006 | 2896 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 14417 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 7048 | 0.010 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 1993 | 295 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2007 | 3615 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 1996 | 1814 | 0.010 |
Why?
|
| Remission Induction | 1 | 1996 | 2397 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2001 | 4142 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2002 | 4544 | 0.010 |
Why?
|
| Cough | 1 | 1994 | 594 | 0.010 |
Why?
|
| Methotrexate | 1 | 1996 | 1719 | 0.010 |
Why?
|
| Hospitals, Rural | 1 | 1991 | 176 | 0.010 |
Why?
|
| Neutropenia | 1 | 1995 | 885 | 0.010 |
Why?
|
| Radiotherapy | 1 | 1996 | 1498 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2002 | 3847 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 6131 | 0.000 |
Why?
|
| Antirheumatic Agents | 1 | 1999 | 1373 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 18255 | 0.000 |
Why?
|
| Diarrhea | 1 | 1994 | 1318 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2001 | 12794 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 2001 | 18966 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2001 | 23447 | 0.000 |
Why?
|